Literature DB >> 11251949

Activity, expression, and transcription rate of the cathepsins B, D, H, and L in cutaneous malignant melanoma.

E Fröhlich1, B Schlagenhauff, M Möhrle, E Weber, C Klessen, G Rassner.   

Abstract

BACKGROUND: Increased activity of the protease cathepsin B has been demonstrated in many tumor cells. A correlation of cathepsin B activity and metastatic potential of melanoma has been well established.
METHODS: The cathepsins B, D, H, and L were evaluated in normal skin, nevi, and melanoma samples to obtain information about their role and their regulation in melanoma. The authors localized specific proteolytic activity with histochemistry, cathepsin protein immunohistochemistry, and mRNA with in situ hybridization.
RESULTS: Activities and immunoreactivities of the cathepsins B and L were found to be increased in all melanocytic lesions. However, the staining for the corresponding mRNA levels was elevated only in melanomas. Cathepsin D protein and mRNA were expressed to a higher degree only in the dysplastic nevus and in melanomas. The increase was due to tumor cells and cells of the surrounding tissue. Cathepsin H activity, immunoreactivity, and mRNA appeared to be correlated inversely with the invasive potential of the lesion.
CONCLUSIONS: It may be relevant for the malignant potential of the lesion whether the increase in activity is accompanied by an increase in the mRNA level. Two different mechanisms-the existence of different mRNAs and the higher transcription rate of the cathepsin gene-have been proposed for the regulation of cathepsin B activity in tumor cells. The current data suggest that, depending on the thickness of the melanoma, cathepsin activity is regulated by different mechanisms. The up-regulation of cathepsin gene transcription appears to be characteristic for more invasive tumor cells. Copyright 2001 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11251949

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  21 in total

Review 1.  Cathepsin L targeting in cancer treatment.

Authors:  Dhivya R Sudhan; Dietmar W Siemann
Journal:  Pharmacol Ther       Date:  2015-08-20       Impact factor: 12.310

2.  Screening of differently expressed genes in human prostate cancer cell lines with different metastasis potentials.

Authors:  Anping Song; Guoning Liao; Mingfu Wu; Yunping Lu; Ding Ma
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-10

3.  Effects of some antituberculous and anti-leprotic drugs on cathepsins B, H and L.

Authors:  Ramesh C Kamboj; Neera Raghav; Ashwani Mittal; Shiwani Khurana; Rachna Sadana; Hari Singh
Journal:  Indian J Clin Biochem       Date:  2003-07

Review 4.  Proteases in cutaneous malignant melanoma: relevance as biomarker and therapeutic target.

Authors:  Eleonore Fröhlich
Journal:  Cell Mol Life Sci       Date:  2010-08-05       Impact factor: 9.261

5.  Deletion of cathepsin H perturbs angiogenic switching, vascularization and growth of tumors in a mouse model of pancreatic islet cell cancer.

Authors:  Vasilena Gocheva; Xiaoping Chen; Christoph Peters; Thomas Reinheckel; Johanna A Joyce
Journal:  Biol Chem       Date:  2010-08       Impact factor: 3.915

6.  Comparison of gene expression between metastatic derivatives and their poorly metastatic parental cells implicates crucial tumor-environment interaction in metastasis of head and neck squamous cell carcinoma.

Authors:  Zhuo Chen; Kun Zhang; Xin Zhang; Xiao H Yuan; Zhenyu Yuan; Li Jin; Momiao Xiong
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

7.  Antitumor effects in vitro and in vivo and mechanisms of protection against melanoma B16F10-Nex2 cells by fastuosain, a cysteine proteinase from Bromelia fastuosa.

Authors:  Carla A Guimarães-Ferreira; Elaine G Rodrigues; Renato A Mortara; Hamilton Cabral; Fabiana A Serrano; Ricardo Ribeiro-dos-Santos; Luiz R Travassos
Journal:  Neoplasia       Date:  2007-09       Impact factor: 5.715

8.  RNAi-mediated abrogation of cathepsin B and MMP-9 gene expression in a malignant meningioma cell line leads to decreased tumor growth, invasion and angiogenesis.

Authors:  Padmaja Tummalapalli; Daniel Spomar; Christopher S Gondi; William C Olivero; Meena Gujrati; Dzung H Dinh; Jasti S Rao
Journal:  Int J Oncol       Date:  2007-11       Impact factor: 5.650

9.  Current concepts of metastasis in melanoma.

Authors:  Blazej Zbytek; J Andrew Carlson; Jacqueline Granese; Jeffrey Ross; Martin C Mihm; Andrzej Slominski
Journal:  Expert Rev Dermatol       Date:  2008-10

10.  Cystatin E/M suppresses legumain activity and invasion of human melanoma.

Authors:  Jon J Briggs; Mads H Haugen; Harald T Johansen; Adam I Riker; Magnus Abrahamson; Øystein Fodstad; Gunhild M Maelandsmo; Rigmor Solberg
Journal:  BMC Cancer       Date:  2010-01-15       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.